Leaflet LANSOPRAZOL LICONSA 15mg gastro-resistant tablets


Indicated for: peptic ulcer; gastroesophageal reflux

Substance: lansoprazole (proton pump inhibitor)

ATC: A02BC03 (Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors)

Lansoprazole is a medication used to treat gastrointestinal conditions such as gastroesophageal reflux disease (GERD), gastric ulcers, and duodenal ulcers. It belongs to the class of proton pump inhibitors (PPIs) and works by reducing the production of stomach acid.

The medication is taken orally, usually once daily before meals. Lansoprazole is effective in relieving heartburn symptoms and promoting the healing of the gastric lining.

Side effects may include headaches, nausea, diarrhea, or constipation. In rare cases, long-term use may lead to vitamin B12 deficiency or an increased risk of bone fractures.

Patients should strictly follow their doctor's instructions and inform them about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about LANSOPRAZOL LICONSA 15mg

  • Substance: lansoprazole
  • Date of last drug list: 01-08-2018
  • Commercial code: W64614001
  • Concentration: 15mg
  • Pharmaceutical form: gastro-resistant tablets
  • Quantity: 14
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for lansoprazole

Concentrations available for lansoprazole

  • 15mg
  • 30mg